Health Condition 1: C139- Malignant neoplasm of hypopharynx,unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
TATA MEMORIAL HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: 1. Cases of squamous cell carcinoma of the larynx/hypopharynx, treated between 2017-2021, receiving organ preservation treatment.
Exclusion criteria
Exclusion criteria: 1. Patients undergoing upfront surgery, 2. Patients who received treatment outside of the treating centre.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the larynx salvage rates for recurrences/residual disease following concurrent chemoradiotherapy (CCRT) for organ preservation in laryngeal and hypopharyngeal carcinoma across the country.Timepoint: Being a retrospective study of review of electronic medical records the following details - Clinical and demographic details - Investigations - Treatment received- details of the organ preservation protocol. - Follow up. - Recurrences/residual disease. - Salvage treatment. of patients diagnosed with squamous cell carcinoma of the larynx/hypopharynx, treated between 2017-2021, receiving organ preservation treatment were extracted. | — |
Secondary
| Measure | Time frame |
|---|---|
| • Type of organ preservation protocol delivered • Larynx preservation rates Timepoint: Being a retrospective study of review of electronic medical records the following details - Clinical and demographic details - Investigations - Treatment received- details of the organ preservation protocol. - Follow up. - Recurrences/residual disease. - Salvage treatment. of patients diagnosed with squamous cell carcinoma of the larynx/hypopharynx, treated between 2017-2021, receiving organ preservation treatment were extracted. | — |
Countries
India
Contacts
Public ContactDr SHIVAKUMAR THIAGARAJAN
TATA MEMORIAL HOSPITAL
Outcome results
None listed